Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

SEPSFAsep Medical Holdings Inc.

OTC · CIK 0001969766
Filer category—
Entity typeother
SIC2835 In Vitro & In Vivo Diagnostic Substances
FY end1231
XBRL facts0

Identity from submissions API

NameAsep Medical Holdings Inc.
CIK0001969766
TickersSEPSF
ExchangesOTC
Entity typeother
Category—
SIC2835 In Vitro & In Vivo Diagnostic Substances
EIN000000000
LEI—
Fiscal year end1231
State of incorporationA1 British Columbia, Canada
Phone1-778-600-0509
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)0
Insider transactions (owner)0

Former names

  • None listed.
Business address
420-730 VIEW STREET
VICTORIA
A1
V8W 3Y7
British Columbia, Canada
Mailing address
420-730 VIEW STREET
VICTORIA
A1
V8W 3Y7
British Columbia, Canada

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

No Financialist filing articles yet for this CIK.

SEC filings

8 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2025-09-10 SEC STAFF ACTION filename1.pdf 9999999997-25-003477 3956
2024-10-04 F-1/A formf-1a.htm 0001493152-24-039534 333-279801 241355350 33 13023292
2024-08-09 F-1/A formf-1a.htm 0001493152-24-031003 333-279801 241193309 33 13025690
2024-05-29 F-1 formf-1.htm 0001493152-24-021827 333-279801 24999761 33 54444609
2024-01-19 DRS/A filename1.htm 0001493152-24-003062 377-06766 24545673 33 3734282
2023-12-12 DRS/A filename1.htm 0001493152-23-044567 377-06766 231481756 33 3664792
2023-10-20 DRS/A filename1.htm 0001493152-23-037860 377-06766 231337521 33 3717029
2023-07-03 DRS filename1.htm 0001493152-23-023196 377-06766 231062937 33 3663709

Latest XBRL company facts

SEC 404 https://data.sec.gov/api/xbrl/companyfacts/CIK0001969766.json

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
No XBRL companyfacts for this CIK.

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →